Controlled Lipid Self-Assembly for Scalable Manufacturing of Next-Generation Immune Stimulating Complexes
Invention type: Technology
/
Case number: #24582H
Researchers
Departments: Chemical Engineering, Department of Biological Engineering, Office of the Provost
Technology Areas: Chemicals & Materials: Nanotechnology & Nanomaterials / Therapeutics: Vaccines
Impact Areas: Healthy Living
-
controlled lipid self-assembly for scalable manufacturing of next-generation immune stimulating complexes
Patent Cooperation Treaty | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.